12:00 AM
 | 
Jul 31, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Enbrel etanercept: Pilot data; marketed to treat rheumatoid arthritis (RA)

Researchers published in The Lancet results of a 3-month, 60-patient investigator-sponsored study (see BioCentury, Aug. 23, 1999). A total of 26 Enbrel-treated patients met psoriatic arthritis response criteria compared to...

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >